MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 23, 2023
app pub date -
Mar 10, 2023
filing date -
Mar 10, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of Parkinson's disease (PD) by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181). The present invention provides a method for treatment of retinal degeneration by administering an expression-based RNA therapeutic that uses virus-based delivery of anti-miR181 (TuD-181).
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully